Alcon (ALC) Long-Term Debt Repayments (2009)
Alcon (ALC) posted Long-Term Debt Repayments of -$5.0 million for Q4 2009, down 400.0% on a QoQ basis from -$1.0 million in Q1 2009.
Powered by 
Analysis
Alcon (ALC) Long-Term Debt Repayments (2009) Analysis & Trends
Alcon has reported Long-Term Debt Repayments for 1 years, with the latest figure at -$5.0 million in Q4 2009.
- On a quarterly basis, Long-Term Debt Repayments changed N/A year-over-year to -$5.0 million in Q4 2009; TTM through Sep 2010 was -$5.0 million, a 400.0% decrease from a year earlier, with the FY2009 full-year figure at -$6.0 million, changed N/A from the prior year.
- Long-Term Debt Repayments was -$5.0 million for Q4 2009 at Alcon, down from -$1.0 million in the prior quarter.
- The five-year high for Long-Term Debt Repayments was -$1.0 million in Q1 2009, with the low at -$5.0 million in Q4 2009.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 1.41 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 17.73 Bn | 17.32 Bn | 1.54 Bn | - |